Senior Director, Investor Relations

Vir Biotechnology, Inc. is an immunology company focused on combining cutting-edge technologies to treat and prevent infectious diseases and other serious conditions. Vir has assembled two technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current clinical development pipeline consists of product candidates targeting hepatitis B and hepatitis delta viruses, influenza A and B, human immunodeficiency virus and COVID-19. Vir has several preclinical candidates in its pipeline, including RSV/MPV and HPV.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company passionate about equality, inclusion, and respect. When everyone feels supported and encouraged to give their best, we will collectively deliver outstanding results. We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.

The Senior Director, Investor Relations, will collaborate to build a strategic investor relations program to communicate our mission and progress to the investment community. Reporting to the EVP, Chief Corporate Affairs Officer, the Senior Director, Investor Relations, will work with senior management, corporate communications, and multiple other leaders across the company. As a team contact with the investment community, this is an important leadership role for Vir with responsibilities that span strategy and planning, content development and communication, and insights.

This is a fully remote position. Vir only supports remote employees within the United States and reserves the right to approve work locations.

RESPONSIBILITIES AND LEARNING OPPORTUNITIES:

Strategy and Planning

• Collaborate to develop annual strategic investor relations program to communicate our strategies and progress to the investment community and adapt the program pending internal and external events
• Participate in banking conferences, non-deal roadshows
• Lead R&D days, analyst days, bus tours, and 1-1 meetings

Content Development and Communication

• Develop an in-depth understanding of our technologies, programs, operations, financial performance, partners, competitors, and strategies
• Improve investor communications, including: corporate presentation decks, earnings releases, earnings and other conference call scripts, management Q&As, website content, the business section of Form 10-K
• Contribute to Board materials, other company press releases, and SEC documents (e.g., Form 8- Ks, Form S-3 fillings)
• Create briefing materials for management in preparation for investor meetings

Analysis and Insights

• Team contact for the investment community, maintain database of interactions, and convey sentiments and feedback to management
• Analyze shareholder base and investment trends for our company, its peers, and its competitors to inform investor targeting strategy and monitor impact of strategy over time
• Follow sell-side models, including comparison to internal forecasts, to assess expectations and determine possible effects for analyst and investor communications
• Work with Competitive Intelligence function and other leaders across the company to understand competitor performance, and industry, regulatory, and other relevant trends, to inform unique corporate messaging

Additional Responsibilities

• Lead corporate ESG programs
• Collaborate on execution of the annual meeting of stockholders
• Partner with legal and corporate communications team to ensure all external communications are accurate, consistent with corporate messaging, and compliant with securities regulations

QUALIFICATIONS AND EXPERIENCE:

• At least 10 years of investor relations experience in a publicly traded biotech/pharmaceutical company, at an investor relations firm working with biotech/pharmaceutical clients, or on the buy or sell-side working in biotech/pharmaceuticals
• BA/BS required, MBA, M.D., or relevant Ph.D. desired
• Outstanding written and oral communication skills
• Ability to present and respond to questions about complex scientific and clinical data
• Deep understanding of capital markets and the financial statements and valuation models used by investors and analysts
• Well versed in SEC and FDA regulations impacting investor and other external communications
• Highly collaborative working style across internal and external teams

#LI-225024411_AA1

#LI-Remote

Vir’s compensation and benefits are aligned with the current market and commensurate with the person’s exper